Despite conclusive evidence young children have virtually no risk of severe complications or death from COVID-19, Pfizer, at the urging of federal health officials, is hustling to get infants and toddlers injected with experimental COVID vaccines.
Story at-a-glance:
- Feb. 1 Pfizer/BioNTech asked the U.S. Food and Drug Administration to grant emergency use authorization (EUA) for their COVID shot to babies and children aged 6 months through 4 years.
- The EUA will be for a two-dose regimen, with the possibility of extending it to a third dose, as two injections have been shown to be ineffective in 2- to 4-year-olds.
- Children aged 6 months to 4 years will get a dose that is one-tenth the adult dose.
- Were Pfizer to wait until the triple-dose experiment is completed, the EUA request would not be possible until late March 2022, and federal officials are reportedly “anxious to begin a vaccination program for the youngest children because the studies showed there were no safety concerns with two doses.”
- Meanwhile, Pfizer’s own data raise massive safety concerns, as they received 42,086 injury reports, including 1,223 fatalities in the first 2.5 months of their COVID jab rollout for adults.
I’m sure you’re aware of the massive catastrophe we have with children under 5 dropping ill like flies from COVID, as this is the justification Pfizer is using to get an Emergency Use Authorization (EUA) so they can jab these defenseless and innocent children. No? Me, neither.
Despite conclusive evidence that young children have virtually no risk of severe complications or death from COVID-19, Pfizer is hustling to get our infants and toddlers injected with their experimental gene transfer technology.
Feb,1 Pfizer/BioNTech asked the U.S. Food and Drug Administration to grant emergency use authorization (EUA) for their COVID shot to babies and children aged 6 months through 4 years.
In mid-December 2021, Pfizer admitted that two injections, at one-tenth the adult dose, failed to produce an adequate immune response in 2- to 4-year-olds. They’re now experimenting to see if three doses will produce adequate results in that age group.
In the meantime, the EUA will be for a two-dose regimen, with the possibility of extending it to a third dose.
As reported by The New York Times, were Pfizer to wait until the triple-dose experiment is completed, the EUA request would not be possible until late March, and federal officials are reportedly “anxious to begin a vaccination program for the youngest children because the studies showed there were no safety concerns with two doses.”
In other words, they apparently don’t care whether the shots are effective or not. They claim the shots are “safe,” so it’s OK to inject young children even though they might not gain any benefit. Does that make any sense?
“[Pfizer] and its partner BioNTech said that the submission was at the request of the FDA, which is an unusual move. Quickly after the announcement, the FDA scheduled a meeting of its vaccine advisory committee for Feb. 15 to discuss the application.
“Allowing Pfizer to submit the request now means that, if authorized, ‘parents will have the opportunity to begin a COVID-19 vaccination series for their children while awaiting potential authorization of a third dose,’ according to Pfizer CEO Albert Bourla. Data on the third dose will be submitted to the FDA ‘in the coming months,’ the company said.”
COVID shots shown to destroy immune function…
Continue reading the full story [icon name=”arrow-right” prefix=”fas”] FDA ‘Anxious’ for Pfizer to Rush COVID Shots for Babies and Toddlers. But Why? • Children’s Health Defense